Gong Cha

Odylia Therapeutics Inc. is a nonprofit biotechnology company based in Boston, MA, dedicated to developing therapies for rare diseases that currently lack available treatments. By integrating scientific knowledge, operational excellence, and technological innovation, Odylia aims to deliver hope and improved health outcomes for both current and future generations of patients. With a focus on patient-centered approaches, Odylia operates under a unique nonprofit drug development model that seeks to overcome the economic barriers of traditional methods. The organization relies on contributions from individuals, nonprofit organizations, patient groups, and corporate donors to accelerate drug development timelines and reduce costs, ultimately bringing life-changing treatments to underserved patient communities. Generated from the website